Community - Public Portfolios & Trending Stocks | AllInvestView

Earnings Recaps

Browse reported earnings of the most popular stocks

Aug 14, 2026 Aug 13, 2026 Aug 12, 2026 Aug 11, 2026 Aug 10, 2026 Aug 9, 2026 Aug 8, 2026 Aug 7, 2026 Aug 6, 2026 Aug 5, 2026 Aug 4, 2026 Aug 3, 2026 Aug 2, 2026 Aug 1, 2026 Jul 31, 2026 Jul 30, 2026 Jul 29, 2026 Jul 28, 2026 Jul 27, 2026 Jul 26, 2026 Jul 25, 2026 Jul 24, 2026 Jul 23, 2026 Jul 22, 2026 Jul 21, 2026 Jul 20, 2026 Jul 19, 2026 Jul 18, 2026 Jul 17, 2026 Jul 16, 2026 Jul 12, 2026 Jul 11, 2026 Jul 10, 2026 Jul 9, 2026 Jul 3, 2026 Jul 2, 2026 Jul 1, 2026 Jun 30, 2026 Jun 28, 2026 Jun 27, 2026 Jun 26, 2026 Jun 25, 2026 Jun 24, 2026 Jun 20, 2026 Jun 19, 2026 Jun 18, 2026 Jun 17, 2026 Jun 15, 2026 Jun 14, 2026 Jun 13, 2026 Jun 12, 2026 Jun 11, 2026 Jun 10, 2026 Jun 9, 2026 Jun 6, 2026 Jun 5, 2026 Jun 4, 2026 Jun 3, 2026 Jun 2, 2026 Jun 1, 2026 May 31, 2026 May 30, 2026 May 29, 2026 May 28, 2026 May 27, 2026 May 26, 2026 May 24, 2026 May 23, 2026 May 22, 2026 May 21, 2026 May 20, 2026 May 19, 2026 May 18, 2026 May 17, 2026 May 16, 2026 May 15, 2026 May 14, 2026 May 13, 2026 May 12, 2026 May 11, 2026 May 10, 2026 May 9, 2026 May 8, 2026 May 7, 2026 May 6, 2026 May 5, 2026 May 4, 2026 May 3, 2026 May 2, 2026 May 1, 2026 Apr 30, 2026 Apr 29, 2026 Apr 23, 2026 Apr 22, 2026 Apr 21, 2026 Apr 20, 2026 Apr 18, 2026 Apr 17, 2026 Apr 16, 2026 Apr 15, 2026 Apr 14, 2026 Apr 13, 2026 Apr 10, 2026 Apr 9, 2026 Apr 8, 2026 Apr 7, 2026 Apr 2, 2026 Apr 1, 2026 Mar 31, 2026 Mar 30, 2026 Mar 26, 2026 Mar 25, 2026 Mar 20, 2026 Mar 19, 2026 Mar 18, 2026 Mar 17, 2026 Mar 16, 2026 Mar 13, 2026 Mar 12, 2026 Mar 11, 2026 Mar 9, 2026 Mar 7, 2026 Mar 6, 2026 Mar 5, 2026 Mar 4, 2026 Mar 3, 2026 Mar 2, 2026 Feb 28, 2026 Feb 27, 2026 Feb 26, 2026 Feb 25, 2026 Feb 24, 2026 Feb 23, 2026 Feb 21, 2026 Feb 20, 2026 Feb 19, 2026 Feb 18, 2026 Feb 17, 2026 Feb 14, 2026 Feb 13, 2026 Feb 12, 2026 Feb 11, 2026 Feb 10, 2026 Feb 9, 2026 Feb 7, 2026 Feb 6, 2026 Feb 5, 2026 Feb 4, 2026 Feb 3, 2026 Feb 2, 2026 Jan 31, 2026 Jan 30, 2026 Jan 29, 2026 Jan 28, 2026 Jan 27, 2026 Jan 26, 2026 Jan 23, 2026 Jan 22, 2026 Jan 21, 2026 Jan 20, 2026 Jan 17, 2026 Jan 16, 2026 Jan 15, 2026 Jan 14, 2026 Jan 9, 2026 Jan 8, 2026 Jan 7, 2026 Jan 6, 2026 Dec 19, 2025 Dec 18, 2025 Dec 17, 2025 Dec 12, 2025 Dec 11, 2025 Dec 10, 2025 Dec 9, 2025 Dec 6, 2025 Dec 5, 2025 Dec 4, 2025 Dec 3, 2025

39 companies Today

Hang Lung Group Limited

0010.HK Q2 2026

Reported: 2026-08-04

Hang Lung's shares dropped 3.2% following earnings, driven by a significant provision in Wuhan serviced apartments that sharply weighed on profitability despite stable core leasing revenue and modest sales growth. The cautious tone on certain segments and margin pressure also disappointed investors.

Key takeaways

A noncash provision of $124 million related to Wuhan serviced apartments skewed reported profitability, turning underlying net profit into a loss.
Core leasing revenue increased 5% with operating profit up 4%, though underlying profit remained flat due to higher capitalized interest expenses.
Mainland rental revenue grew 3% overall, buoyed by retail (+6%), while office segment weakened with a 12% decline amid ongoing supply and competition challenges.
Property sales generated over $1 billion in revenue but included some loss-making transactions from prior periods impacting margins.
Retail sales in Mainland remained strong, with 7 out of 10 operating malls achieving record sales and active customer engagement up significantly, yet segment weaknesses in office and serviced apartments contributed to a cautious outlook.

American Homes 4 Rent

AMH Q2 2026

Reported: 2026-08-04

The 3.9% stock increase reflects solid execution on leasing and development efforts, with upside driven by accelerating rental rate growth, disciplined capital allocation, and an increased core FFO per share outlook.

Key takeaways

Core FFO per share guidance midpoint was raised by $0.03 to $1.95, indicating 4.3% year-over-year growth.
Same-home occupancy held steady at 96%, with blended rental rate growth accelerating to 2.7% for the quarter and 2.8% in July.
Controllable expense growth was limited to less than 1% year-over-year despite expansion efforts.
Delivered 651 new homes in the quarter, including 542 to the wholly owned portfolio, supporting NOI growth from development.
Disposition activity remains robust with over 1,300 homes sold year-to-date, generating approximately $380 million of net proceeds to fund on-balance-sheet development.

AutoNation, Inc.

AN Q2 2026

Reported: 2026-08-04

Shares declined 1.0% following AutoNation’s Q2 report, reflecting investor reservations amid ongoing new vehicle sales headwinds, notably a 30% drop in BEV sales, and cautious commentary on vehicle mix challenges despite stable margins and solid aftersales growth.

Key takeaways

Adjusted EPS rose modestly to $5.56 from $5.46 year-over-year, marking the sixth consecutive quarter of year-over-year growth.
Aftersales gross profit increased 7% overall and 4% on a same-store basis, driven by a 7% increase in customer pay revenue and 16% growth in wholesale parts.
New vehicle sales declined, weighed down by a 30% year-over-year drop in BEV sales and the absence of 2025 tariff-related pull-forward demand; used vehicle volume was impacted by lower availability of sub-$20,000 units.
Total gross margin held steady just under 18% of revenue, reflecting continued margin discipline despite volume pressures.
Adjusted free cash flow remained strong, generating $180 million in the quarter and $439 million year-to-date, supporting $457 million in share repurchases and $317 million in acquisitions.

BrightSpring Health Services, Inc. Common Stock

BTSG Q2 2026

Reported: 2026-08-04

BrightSpring’s shares declined sharply by 17% following the report, primarily reflecting investor disappointment with the cautious outlook and impact from exit of certain skilled nursing customers, which weighed on segment growth and margin outlook.

Key takeaways

Total revenue grew 23% year-over-year to $3.9 billion, with adjusted EBITDA up 44% to $206 million.
Pharmacy Solutions revenue increased 22% to $3.4 billion, driven by strong branded oncology LDD portfolio and specialty scripts up 31%, but generic script contribution tempered.
Home and Community Pharmacy segment was negatively affected by the exit of skilled nursing customers, impacting volume and revenue despite improved profitability from operational efficiencies.
Provider Services revenue rose 30% to $466 million with adjusted EBITDA up 33%, fueled by Home Health care volume growth, acquisitions, and strong quality metrics, yet integration risks remain.
Management highlighted opportunities ahead but took a cautious tone on growth and margins, contributing to negative investor reaction.

Cboe Global Markets, Inc.

CBOE Q2 2026

Reported: 2026-08-04

Cboe shares rose 4.6% following a quarter that delivered record net revenue and strong earnings growth, driven primarily by exceptional volume gains in derivatives and a bullish outlook on expanding event and prediction market products.

Key takeaways

Net revenue grew 25% year-over-year to a record $732 million, led by all five company segments.
Adjusted diluted EPS increased 45% year-over-year to $3.56, reflecting operational leverage across the business.
Derivatives net revenue hit $413 million, up 30%, with index options average daily volume up 32% to 6.2 million contracts.
Notable product-level volume records include SPX options (+40% YoY), SPX 0DTE (+11% MoM in June), and Mini-SPX (+80% YoY).
The company launched Cboe Predicts, targeting simple outcome-based products, and filed to list contracts tied to company performance metrics, positioning for growth beyond traditional options.

Cameco Corporation

CCO.TO Q2 2026

Reported: 2026-08-04

Cameco shares declined 2.1% post-earnings as investors appear cautious despite management’s positive framing; operational disruptions and a slower contribution from Westinghouse weighed on near-term results.

Key takeaways

Production outlook for 2026 remains unchanged at 19.5 to 21.5 million pounds of U3O8, despite temporary operational disruptions at Key Lake, McArthur River, and a brief suspension at Cigar Lake.
The second quarter financial results were lower compared to last year’s strong Q2, mainly due to reduced contribution from Westinghouse’s Dukovany reactor project participation.
Realized prices improved in both uranium and fuel services segments, benefitting from a stronger U.S. dollar impacting exchange rate assumptions.
Continued contracting discipline was highlighted, with more than 28 million pounds per year secured under contract for the next five years, focusing on downside protection and future market upside.
Near-term operational challenges underline the complexity and risks inherent in Cameco’s mining assets despite strong long-term fundamentals.

Colgate-Palmolive Company

CL Q2 2026

Reported: 2026-08-04

Colgate-Palmolive shares edged down 0.3% following Q2 results as modest U.S. underperformance and category softness in Pet pressured sentiment despite broad-based global growth and solid margin management.

Key takeaways

Organic sales grew in 4 of 5 divisions and 3 of 4 categories, led by mid-single digit growth in emerging markets including India, Brazil, Mexico, and China.
Hill's Pet Nutrition segment outpaced the soft pet category with 4% organic growth ex-private label disruption, though pricing was the main driver behind pet sales growth.
U.S. business showed signs of weakness requiring targeted category and channel actions to improve market share and heightened brand investments in H2.
Gross margins expanded before a modest tariff benefit; the company maintained profit and EPS growth amid significant cost inflation.
Free cash flow rose 18% with $1.4 billion returned to shareholders, supporting financial discipline and shareholder returns.

Clariant AG

CLN.SW Q2 2026

Reported: 2026-08-04

Clariant's shares rose modestly by 2.8% following Q2 results that showed stable sales and margin improvements amid ongoing headwinds from the Middle East conflict. The market appears to have taken a cautiously positive view on pricing actions and cost savings offsetting volume declines, particularly in the Catalysts segment.

Key takeaways

Group sales were essentially flat (-0.3% in local currency including portfolio changes; +0.6% on underlying basis).
Pricing increased 3% across all business units, helping offset inflationary raw material costs.
Volumes declined 3.3% overall, with a sharp 14.2% drop in Catalysts largely tied to Middle East disruptions.
EBITDA margin before exceptional items improved by 80 basis points to 18.2%, driven by pricing and volume gains in Care Chemicals and inventory valuation effects.
Performance improvement programs delivered CHF 10 million savings in Q2, with a raised target of CHF 90 million run rate savings by end-2026, despite restructuring charges of CHF 24 million.

Cellnex Telecom, S.A.

CLNX.MC Q2 2026

Reported: 2026-08-04

Cellnex’s shares declined modestly by 0.7% as investors tempered enthusiasm despite steady organic growth and margin expansion, reflecting cautious sentiment amid limited upside surprises and a reiteration rather than an upgrade of guidance.

Key takeaways

Organic revenues increased by 5% year-on-year, driven by price escalators and sustained customer demand.
Adjusted EBITDA rose 6.4%, with EBITDA after leases up 7.7%, supported by operational efficiencies and land management actions.
Recurrent levered free cash flow grew 11%, while free cash flow per share increased 18.1%, reflecting disciplined capital allocation and operational execution.
Points of Presence expanded 4.9% net, highlighting ongoing demand despite market consolidation.
Shareholder remuneration remains a focus, with EUR 1 billion to be returned in 2026 combining dividends and share buybacks, including a newly approved EUR 200 million share repurchase program.

Capstone Copper Corp.

CS.TO Q2 2026

Reported: 2026-08-04

The stock rose 4.0% following Q2 results that highlighted better-than-expected operational performance and financial metrics, underpinned by record throughput, low cash costs, and strong copper prices, driving record EBITDA for the seventh consecutive quarter.

Key takeaways

Consolidated copper production increased to 51.8k tonnes with C1 cash costs of $2.82/lb, reflecting operational efficiency, particularly at Mantoverde and Mantos Blancos.
Realized copper prices averaged $6.22/lb, supporting gross margins of $3.40/lb or 55.0%, despite inflationary pressures.
Adjusted EBITDA reached a record $354 million, an 8.0% increase quarter-over-quarter and 64.0% year-over-year.
Net debt decreased by $63 million quarter-over-quarter to $675 million, lowering the net debt-to-EBITDA ratio to 0.5x.
The company reaffirmed 2026 guidance and highlighted ongoing growth projects (MDO and Santo Domingo) positioning Capstone for approximately 70% production growth over 2025 levels.

Eastman Chemical Company

EMN Q2 2026

Reported: 2026-08-04

Eastman’s shares dipped modestly (-0.2%) after Q2 results, as investors balanced solid volume gains against cautious commentary on weak end markets and uncertain margin outlooks, particularly in Chemical Intermediates.

Key takeaways

Advanced Materials posted solid volume and mix growth in Q2, supported by innovation wins and a modest ramp in circular business volumes.
Management flagged no expected improvement in weak discretionary end markets (auto, building & construction, consumer durables) through the second half.
Utilization is set to improve in H2 as previously built inventory converts, supporting margins without additional cash outlays.
Chemical Intermediates saw robust volume increases driven by the absence of shutdowns versus last year, but margin prospects remain uncertain due to geopolitical risks.
Additives & Functional Products experienced normal seasonal declines, tempering overall segment performance.

Enbridge Inc.

ENB.TO Q2 2026

Reported: 2026-08-04

Enbridge shares declined 1.7% post-earnings as investors weighed solid operational progress against a cautious stance on near-term growth and muted margin commentary.

Key takeaways

Mainline pipeline volumes averaged 3.1 million barrels per day in Q2, maintaining strong utilization across all four business segments.
Commissioning of the Blackcomb pipeline and start of operations at the Houston Oil Terminal mark key infrastructure milestones.
Sanctioned approximately $1 billion for the Wisconsin Line 5 Relocation, continuing steady capital deployment.
Visibility on up to $20 billion in new projects for 2026-27 supports growth outlook but without aggressive near-term guidance revisions.
Management highlighted a favorable policy environment and customer demand but provided limited detail on margin expansion or acceleration in key metrics.

Euronext N.V.

ENX.PA Q2 2026

Reported: 2026-08-04

Euronext’s Q2 2026 results impressed investors, with a 5.2% stock increase driven by broad-based double-digit revenue growth, margin expansion, and strategic progress in new initiatives.

Key takeaways

Revenue rose 16.9% year-on-year to EUR 544.4 million, marking a record quarter.
Adjusted EBITDA increased 21.1% to EUR 360 million, lifting the margin 2.3 percentage points to 66.1%.
Adjusted net income grew 19.9% to EUR 245 million, and EPS reached EUR 2.42, up 19.8%.
Both volume-related (up 19.2%) and non-volume-related (up 15.2%) revenues contributed to growth, supported by strategic acquisitions and new product launches (e.g., Power Futures).
Net debt to last 12 months EBITDA remained manageable at 1.3x despite EUR 700 million cash outflows for dividends and bond redemption.

Endeavour Silver Corp.

EXK Q2 2026

Reported: 2026-08-04

Endeavour Silver’s shares fell slightly by 0.5% after reporting higher production and record metal sales, but investors appeared wary of rising costs and margin pressure amid increasing royalties, input prices, and sustaining capital spending.

Key takeaways

Q2 silver equivalent production rose 36% year-over-year to nearly 3 million ounces, driven by ramp-up at Terronera and increased throughput at Kolpa.
Revenues grew 150% to $212 million with mine operating earnings of $74 million and mine operating cash flow reaching $100 million before taxes, a 300% jump from prior year.
All-in sustaining costs (net of by-product credits) increased 47% to $37 per ounce due to higher royalties, purchased materials, profit sharing, and mining taxes, pressuring margins.
Direct operating costs per tonne increased 14%, impacted by Mexican peso appreciation and inflationary inputs, despite improvements in plant capacity and operational efficiencies.
The company increased its 2026 capital budget by $18 million for Kolpa expansions and continues to advance ramp-up and exploration initiatives, with a strong $236 million cash position underpinning growth plans.

Fulgent Genetics, Inc.

FLGT Q2 2026

Reported: 2026-08-04

Fulgent Genetics shares dropped 15.7% after the quarter as investors reacted negatively to significant deceleration in the core Precision Diagnostics segment, coupled with continued operational challenges in revenue recognition that pressured near-term revenue visibility and margins.

Key takeaways

Laboratory services revenue grew 4% year-over-year to $85.4 million, boosted by recent acquisitions Bako and StrataDX.
Precision Diagnostics revenue declined 13% year-over-year to $41.5 million, highlighting a key business segment weakness.
Sequential revenue in Precision Diagnostics increased 3%, but ongoing issues in billing and revenue cycle management delayed claim processing and reduced recognized revenue.
Management prioritized resolving revenue cycle inefficiencies but provided a cautious outlook given these operational headwinds.
Encouraging progress in the therapeutic development pipeline, including completion of Phase II data for FID-007 and advancement of FID-022 to Phase I dose escalation, but these remain early-stage with no near-term revenue impact.

Fortis Inc.

FTS.TO Q2 2026

Reported: 2026-08-04

Fortis shares declined 0.9% post-earnings, reflecting investor caution despite stable core utility investments as incremental growth opportunities remain subject to regulatory approvals and timing uncertainties.

Key takeaways

Q2 EPS of $0.78, up $0.02 year-over-year, supported by capital investments across key utility segments.
ITC and UNS each contributed a $0.02 EPS increase, though benefits were partly offset by higher finance costs and regulatory lag.
Expansion of Tilbury LNG Phase 1B presents a significant growth opportunity, but its inclusion in the capital plan is deferred pending further approvals and cost refinements.
Ongoing projects and new contracts (e.g., TEP data center capacity negotiations) signal potential future growth, yet are subject to execution risks.
Corporate segment impacted by unrealized foreign exchange losses, increased finance costs, and lower earnings following the 2025 Fortis Belize disposition.

Societe Generale Societe anonyme

GLE.PA Q2 2026

Reported: 2026-08-04

Société Générale shares rose 6.0% following Q2 2026 results as the bank delivered better-than-expected revenue growth, cost reductions, and capital management, driving a notably stronger return on tangible equity.

Key takeaways

Group revenues rose 4.5% reported (+6.1% at constant perimeter and exchange rates) with French Retail Banking and Global Banking segments showing solid growth.
Operating expenses declined by 4.1% versus Q2 2025, exceeding original 2026 cost reduction targets, resulting in a cost/income ratio improvement to 58.6%, below the year-end target of 60%.
Net income reached a record EUR 1.8 billion for the quarter, translating into a return on tangible equity of 12.2%, well above prior year and the full-year target.
Cost of risk remained contained at 27 basis points within guidance, supported by prudent risk management and stable provisions, with nonperforming loans decreasing to 2.7%.
Capital position remained robust with a CET1 ratio of 13.2% after accounting for the EUR 1.5 billion extraordinary share buyback, maintaining a solid buffer over regulatory minimums.

International Consolidated Airlines Group, S.A.

IAG.MC Q2 2026

Reported: 2026-08-04

Shares fell 1.3% following IAG’s first half 2026 results, reflecting investor caution amid margin pressure from higher fuel costs and mixed performance across key operating segments despite resilient revenue growth and cost discipline.

Key takeaways

Operating profit declined €121 million year-on-year to €1.757 billion, with the operating margin contracting to 10.9%, below the group’s stated full-year target range of 12% to 15%.
Passenger revenue rose modestly by 1.0%, driven primarily by a strong first quarter, but growth slowed significantly in the second quarter to 0.2%, weighed down by capacity constraints and competitive pressures.
Fuel unit costs increased 12.5% due to rising commodity prices and incomplete hedging offsets, significantly impacting profitability, particularly in price-sensitive short-haul segments.
British Airways delivered a modest profit increase (€44 million), contrasting with declines at Iberia (–€38 million), Vueling (–€49 million), and Aer Lingus, which swung to an operating loss (€34 million), reflecting a mix of higher fuel costs, competitive intensity, and operational challenges.
The loyalty business remained a bright spot, with operating profit up 25% to GBP 239 million and margins improving, driven by non-airline partnerships despite disruption from Middle East route suspensions.

Intercontinental Exchange, Inc.

ICE Q2 2026

Reported: 2026-08-04

ICE shares declined modestly by 1.2% following Q2 2026 results, reflecting investor caution despite ongoing strategic initiatives. The market appears hesitant on near-term growth or margin impact amid the pending MarketAxess acquisition and integration challenges.

Key takeaways

Announced agreement to acquire MarketAxess, expanding ICE’s footprint into global fixed income and institutional credit markets.
Emphasized building a connected fixed income network combining retail and institutional liquidity pools to improve price discovery and operational efficiency.
Highlighted ICE's growing treasury futures franchise as its fastest-growing product in the quarter.
Management framed the acquisition as a long-term growth driver but offered limited near-term financial guidance or margin outlook details.
Market reaction suggests investors are cautious about integration risks and the timing of benefits from combining these businesses.

Ingersoll Rand Inc.

IR Q2 2026

Reported: 2026-08-04

Ingersoll Rand’s shares declined 1.1% following Q2 results as investors digested margin pressure driven by inflation and elevated corporate costs, offsetting steady top-line growth and an upbeat full-year revenue outlook.

Key takeaways

Organic revenue grew 4% year-over-year, with total revenue reaching approximately $2 billion, supported by 2% organic order growth.
Adjusted EBITDA increased 2% to $520 million, but margin contracted 160 basis points to 25.4% due to inflation (notably in China), investment in new technologies, and higher corporate costs.
Corporate costs surged to $49 million versus $34.6 million prior year, largely reflecting non-recurring incentive compensation true-ups.
Management raised full-year revenue guidance and anticipates adjusted EPS towards the high end of the prior range, citing expected margin improvement in H2 from pricing and productivity initiatives.
Acquisition activity remains robust, including the closing of Lone Star Blowers and signing of Fai Filtri, enhancing aftermarket and filtration capabilities aligned with strategic focus on recurring revenue.

Leonardo S.p.a.

LDO.MI Q2 2026

Reported: 2026-08-04

Leonardo’s shares edged up 2.6% post-earnings as investors digested a solid strategic update but showed only mild enthusiasm, suggesting cautious sentiment despite significant portfolio advances and partnerships.

Key takeaways

The CEO emphasized acceleration in execution, technology development, and delivery to meet evolving defense needs amid rising multi-domain threats.
Growth drivers include new contracts and program expansion in advanced systems like GCAP sixth-generation aircraft and the Michelangelo integrated air defense system.
Strategic acquisitions, notably the AI-centric U.S. company DRS, and the Iveco land systems purchase, aim to broaden Leonardo’s footprint in emerging defense domains.
Key joint ventures with Baykar (LBA), Rheinmetall, and planned collaboration with Thales/Airbus signal attempts to scale operations and capture new market segments.
The industrial restructuring, particularly in aerostructures, reflects ongoing efforts to improve operational efficiency but underscores existing challenges in certain segments.

Lloyds Banking Group plc

LLOY.L Q2 2026

Reported: 2026-08-04

The 3.0% post-earnings rally reflects investor approval of solid financial results and maintained guidance, with growth in net income and disciplined costs supporting confidence. Market reaction suggests the half-year performance aligned with expectations without major surprises.

Key takeaways

Statutory profit after tax reached GBP 3.1 billion with a return on tangible equity of 17.1%, consistent with the target of above 16%.
Net income increased 9% year-on-year to GBP 9.7 billion, with Q2 net income 4% higher than Q1, driven by both net interest income and other income.
Operating costs remained flat year-on-year at GBP 4.9 billion, enabling a Q2 cost-income ratio of 49%, meeting guidance for sub-50% full-year.
Credit quality remains robust with an impairment charge of GBP 617 million, translating to an asset quality ratio of 25 basis points.
The group announced a 30% increase in the interim dividend and a GBP 1 billion share buyback, reflecting ongoing shareholder returns aligned with strong capital generation.

Wendel

MF.PA Q2 2026

Reported: 2026-08-04

Wendel’s shares edged up 2.3% on earnings, reflecting a broadly in-line performance with modest organic growth and continued shareholder returns, though no clear upside catalyst emerged to push the stock higher.

Key takeaways

Assets under management (AUM) reached EUR 48.7 billion, with fee-paying AUM growing 30% year-over-year and 11% organically, indicating continued but moderate expansion.
Management fees rose 56% to EUR 226 million, driving fee-related earnings up 46% to EUR 87.1 million, highlighting the growing importance of fee stability over performance-related earnings.
EUR 450 million returned to shareholders year-to-date through EUR 140 million in dividends and EUR 310 million via share buybacks, underscoring capital return discipline.
The net asset value (NAV) increased 2.6% quarter-over-quarter after dividends, partially supported by accretive share buybacks despite some modest NAV pressure from lower market multiples on certain holdings.
Dry powder remained elevated at approximately EUR 12 billion, supporting future investment activity but reflecting a cautious deployment environment.

Martin Marietta Materials, Inc.

MLM Q2 2026

Reported: 2026-08-04

Martin Marietta’s shares dropped 7.8% post-earnings, reflecting investor disappointment primarily with cautious commentary on infrastructure demand and a lack of upbeat guidance revision despite recent acquisitions and operational improvements.

Key takeaways

Raised full-year revenue guidance to $7.2-$7.4 billion, but adjusted EBITDA guidance was only reaffirmed at $2.36-$2.5 billion, showing no upward revision despite acquisitions.
Completed acquisition of New Frontier Materials and announced combination with Lhoist North America, strategically expanding aggregates and specialty minerals footprint.
Identified $350 million in run-rate pretax cash flow improvement opportunities; $200 million already realized through inventory and capital spending discipline.
Infrastructure end markets remain stable but management signaled cautious near-term outlook amid uncertainty in transportation funding and legislative timing.
Delivered record second-quarter revenues and adjusted EBITDA, but market reaction suggests these results failed to offset investor concerns over future growth visibility.

Moderna, Inc.

MRNA Q2 2026

Reported: 2026-08-04

Moderna's shares dropped 5.4% following Q2 as investors reacted negatively to cautious revenue guidance coupled with ongoing net losses, despite some margin improvements and pipeline progress.

Key takeaways

Q2 revenue was $145 million, a modest 2% increase year-over-year, coming in above guidance but reflecting continued seasonality in vaccine sales.
The company reiterated up to 10% revenue growth for 2026 but emphasized a balanced U.S./international revenue split, signaling tempered upside.
Net loss improved slightly to $782 million, driven by reduced clinical costs and SG&A expenses, yet cash declined by $600 million to $6.9 billion amid ongoing R&D investments.
Cost of sales fell 22% due to manufacturing efficiencies, but the substantial negative earnings and high cash burn continue to weigh on investor sentiment.
Pipeline advancements, including positive regulatory milestones for the seasonal flu vaccine and progress in oncology programs, provide some long-term upside potential but have not shifted near-term market skepticism.

Patria Investments Limited

PAX Q2 2026

Reported: 2026-08-04

Patria's shares rose modestly by 1.8% following Q2 results that demonstrated steady fundraising and fee-related earnings growth, although concerns remain around markdowns in older private equity vintages and the ongoing adjustment in performance fees.

Key takeaways

Fee-earning AUM grew 7% sequentially and 32% year-over-year to $48.9 billion, driven by organic growth, acquisitions, and strong investment performance in credit, real estate, public equities, and GPMS.
Fundraising reached $2.3 billion in Q2, with year-to-date totals of $4.5 billion; management reiterated confidence in surpassing the full-year $7 billion target and potentially exceeding the 3-year target of $21 billion.
Fee-related earnings (FRE) increased 13% sequentially and 24% year-over-year to $57.1 million, on track for full-year guidance of $225–245 million.
Distributable earnings per share rose 19% sequentially and 31% year-over-year to $0.32.
The older private equity Funds IV and V, representing a small portion of fee-earning AUM, faced markdowns due to prolonged macroeconomic challenges and longer divestment windows; these funds have not generated management or performance fees recently and weigh on segment outlook.

Pilgrim's Pride Corporation

PPC Q2 2026

Reported: 2026-08-04

Shares fell 8.6% following the quarter as investors reacted negatively to sharply compressed margins and cautious supply outlook despite steady demand and volume growth. The steep decline in adjusted EBITDA margin from 14.4% to 7.8% likely drove concerns over cost pressures and margin sustainability.

Key takeaways

Net revenues reached $4.6 billion, supported by firm chicken demand across retail, foodservice, and international markets.
Adjusted EBITDA was $360 million, with margins collapsing to 7.8% from 14.4% a year ago, reflecting significant margin compression.
Volume growth was steady or strong in key categories, including double-digit gains in prepared foods and increased export presence, especially in the Middle East and Asia.
Margin pressure stemmed from competition (notably imported pork in the UK) and higher costs attributed to geopolitical conflicts and energy prices.
USDA forecasts slowing chicken production growth in H2 2026, signaling possible supply-side caution despite resilient demand trends.

Proto Labs, Inc.

PRLB Q2 2026

Reported: 2026-08-04

Proto Labs’ shares were little changed, declining 0.1% as the market digested solid but not breakout results, reflecting steady execution without meaningful new catalysts or concerns in the quarter.

Key takeaways

Revenue rose on continued double-digit growth, driven by 13% growth in Injection Molding and 20% growth in CNC Machining in the factory segment.
Revenue per customer increased 17% year-over-year, signaling deeper engagement with larger, strategic accounts.
European business revenue grew 9% YoY, aligning with early progress from recent go-to-market restructuring, but profitability remains a work in progress.
Gross margins expanded with operating cost leverage, supported by investments in quality and operational efficiency.
Management emphasized ongoing transformation initiatives and a strategic focus on broadening customer relationships, with leadership changes to strengthen commercial and quality functions.

Prysmian S.p.A.

PRY.MI Q2 2026

Reported: 2026-08-04

The stock jumped 4.8% following a quarter that delivered notable organic growth and margin expansion, particularly driven by the digital and transmission segments, signaling investor approval of Prysmian’s transition toward higher-value, fast-growing markets.

Key takeaways

Group organic growth reached 9.4%, with the transmission segment leading at 14.3% growth and a strong EBITDA margin of 21.2%.
Digital solutions delivered an EBITDA margin of 24%, up from 20.6% in Q1, becoming the most profitable segment and benefitting from pricing efficiency and a shift to data center exposure.
Power Grid segment showed sequential EBITDA margin improvement from 12.4% to 13.8%, supported by strong demand across the US and Europe.
Industrial Construction posted EUR 228 million EBITDA with a 13.4% organic growth in the US, despite a EUR 5 million Forex headwind.
Sustainability initiatives continue to advance with 46% of revenues tied to sustainable solutions and 32% of revenues driven by products launched in the last three years, enhancing pricing power and innovation-led growth.

Parex Resources Inc.

PXT.TO Q2 2026

Reported: 2026-08-04

Parex Resources' Q2 production and reserves growth following accretive acquisitions drove a positive market reaction of +3.7%, reflecting investor approval of the company’s expanded asset base and operational momentum.

Key takeaways

Production averaged over 54,000 BOE/day in Q2, including first-month volumes from the Frontera acquisition.
Updated reserves report showed PDP and 1P reserves increased by more than 80%, validating the recent acquisitions.
Second half 2026 production guidance nearly doubled to approximately 86,000 barrels per day at midpoint.
Capital program includes $250 million over 5 years for Magdalena assets with zero upfront acquisition costs, contributing to future growth.
Elevated production costs pressured by energy prices and currency appreciation are at the upper end of guidance, but free cash flow is expected to remain strong.

Siemens Healthineers AG

SHL.DE Q3 2026

Reported: 2026-08-04

The stock rose 5.1% driven by notably strong order intake and upbeat growth in key segments, especially Precision Therapy and new strategic value partnerships, which more than offset ongoing challenges in Diagnostics and a lowered revenue outlook.

Key takeaways

Equipment book-to-bill ratio stood at an impressive 1.27, underpinned by two large value partnerships with leading U.S. health institutions.
Precision Therapy delivered robust 9% growth, while Imaging growth was softer at 5%, impacted by tough prior year comps and temporary revenue timing shifts.
Diagnostics segment continued to face structural headwinds, particularly in China, with no improvement yet in the rate of decline.
The company lowered its fiscal 2026 revenue growth guidance to 3.5%-4.0% (from 4.5%-5.0%), citing continued Diagnostics weakness but raised the EPS guidance due to one-time tariff refunds.
Innovation momentum remains strong, with advances in photon-counting CTs, DryCool MR technology, radiopharmaceutical capacity expansion, and FDA approval of AI-enabled solutions supporting future growth.

Stellantis N.V.

STLA Q2 2026

Reported: 2026-08-04

Stellantis shares declined 4.2% following Q2 results, reflecting investor disappointment with the cautious outlook despite operational improvements and reaffirmed full-year guidance.

Key takeaways

Q2 net revenues increased 13% year-over-year; AOI margin improved by 120 basis points.
Industrial free cash flow was positive EUR 1 billion, up EUR 1 billion from last year.
Production efficiency rose significantly, +870 basis points in North America and +170 basis points in Europe.
Market share gains across key regions; North America sales up 6%, Ram sales up 12%, Chrysler up 54%.
Despite operational progress and strong sales in multiple regions, management reaffirmed full-year guidance without upgrades, signaling caution to investors.

Technip Energies N.V.

TE.PA Q2 2026

Reported: 2026-08-04

Technip Energies' shares declined 8.3% following the earnings release as investors reacted negatively to the guidance cut and significant margin compression driven by operational challenges and ongoing disruption in the Middle East. Despite stable revenues, profitability in the Project Delivery segment took a marked hit amid logistical constraints and contractual disputes.

Key takeaways

Group revenues held steady at EUR 3.7 billion year-over-year, but EBITDA fell by approximately one-third due to higher costs linked to the Middle East conflict.
Project Delivery revenue rose slightly (+1% YoY) but profitability was materially impacted by slower progress and disputed claims in the Middle East.
First half order intake surged to EUR 12.7 billion, lifting the backlog to EUR 25 billion, supporting medium-term growth despite near-term headwinds.
The company reduced Project Delivery margin guidance and warned that cost recovery timing remains uncertain amid ongoing contractual negotiations.
Cash conversion remained strong at 86%, and capital returns to shareholders continued with a EUR 150 million share buyback completed and a EUR 300 million total return plan for 2026.

Teekay Corporation

TK Q2 2026

Reported: 2026-08-04

Teekay Tankers’ shares edged up 1.7% post-earnings, reflecting a broadly in-line performance with strong spot rates supporting results but tempered by ongoing geopolitical risks and mixed outlook on Aframax pricing.

Key takeaways

Reported GAAP net income of $226 million ($6.49/share) and adjusted net income of $194 million ($5.56/share), marking a 50% increase from the previous quarter and setting a quarterly adjusted net income record.
Spot tanker rates hit historic highs in Q2, averaging $109,200/day for Suezmax and $74,100/day for Aframax LR2; however, Aframax rates softened mid-quarter before recovering in July.
Generated ~$200 million in free cash flow from operations and increased cash balance to over $1.2 billion with zero debt following vessel sales and fleet renewal transactions.
Geopolitical disruptions remain significant, with attacks affecting transit through the Strait of Hormuz and Bab el-Mandeb Strait, contributing to volatility and operational uncertainties.
Third quarter booked approximately 44% of spot days at rates of $104,800/day (Suezmax) and $59,900/day (Aframax LR2), indicating some moderation in rate visibility.

T. Rowe Price Group, Inc.

TROW Q2 2026

Reported: 2026-08-04

T. Rowe Price shares fell 6.3% following the quarter as investors reacted to ongoing net outflows and a cautious outlook pointing to continued pressure on fundamental active equity, overshadowing modest positive inflows in select strategies.

Key takeaways

Assets under management ended at $1.9 trillion with $6.5 billion of net outflows in Q2, reflecting persistent pressure in fundamental active equity.
Positive inflows in May and June driven by a large defined contribution win and sub-advisory gains, partially offsetting early-quarter outflows.
Growth areas include integrated equity and fixed income strategies combining fundamental and quantitative research, totaling $200 billion AUM and adding $16 billion net inflows year-to-date.
Active ETFs and SMAs are expanding, with 34 ETFs managing $30 billion and 43 SMAs managing $20 billion.
Management signaled ongoing challenges in fundamental equity but highlighted progress in AI integration and new product launches without providing encouraging guidance for near-term recovery.

Umicore SA

UMI.BR Q2 2026

Reported: 2026-08-04

Umicore’s shares edged up modestly by 1.8% following H1 2026 results that showed broadly steady operational momentum and an upgraded full-year EBITDA guidance. However, the market reaction suggests the upside was somewhat contained by headwinds in the Fuel Cell Catalyst segment and ongoing uncertainty in key growth areas.

Key takeaways

Revenues rose 7% year-on-year to EUR 1.9 billion, supported by broad-based demand and favorable metal prices, particularly in Q1.
Adjusted EBITDA increased 33%, driving margin expansion of approximately 600 basis points to 30.2%, underpinned by strong business execution and efficiency gains.
Full-year adjusted EBITDA guidance was raised slightly above EUR 1 billion, up from the previous “approach to EUR 1 billion,” reflecting confidence but not a large beat.
Catalysis segment showed solid earnings with outperformance versus declining light-duty vehicle production, though Fuel Cell Catalysts faced weakness from postponed hydrogen adoption in China and incurred start-up costs.
Recycling posted exceptional margin expansion to 52% despite a plant maintenance shutdown, benefiting from a broad basket of metal prices and strong volumes in Jewelry & Industrial Metals.

Willis Towers Watson Public Limited Company Ordinary Shares

WTW Q2 2026

Reported: 2026-08-04

WTW’s shares rose 6.3% following a quarter that delivered solid organic growth and margin expansion, driven by broad-based strength in Risk & Broking and ongoing operational efficiencies powered by AI initiatives that appear to have impressed investors.

Key takeaways

Reported 5% organic revenue growth overall, with Risk & Broking leading at 7% and Health, Wealth & Career growing 4%.
Adjusted operating margins expanded by 100 basis points, reflecting disciplined cost management despite global market volatility.
Adjusted diluted EPS increased 17% year-over-year to $3.35.
AI integration accelerated productivity, including schedule generation tasks cut from hours to minutes and public client adoption of AI tools doubling recently.
Launched Propel, an AI Acceleration Plan targeting $400 million in run-rate savings by 2028 through a $625 million investment to drive margin expansion to ~30%.

TMX Group Limited

X.TO Q2 2026

Reported: 2026-08-04

TMX Group’s shares declined modestly by 1.0% following a quarter highlighted by double-digit revenue growth and strong volume metrics, but the lack of a more positive market response suggests investors were cautious despite solid top-line performance and ongoing expansion initiatives.

Key takeaways

Revenue grew 16% year-over-year in the first half of 2026, driven by across-the-board strength in transaction and recurring revenue segments.
Organic revenue, excluding last year’s Global Insights acquisitions, increased by 14%, showing healthy underlying growth.
Adjusted diluted EPS rose 27% year-over-year, reflecting improved operational leverage.
Capital formation revenues increased 20%, supported by a 51% surge in capital raised and a notable 108% jump in equity capital on TSX Venture.
Trading volumes expanded significantly, with a 32% rise in combined equities and derivatives volumes, highlighted by a 60% increase on TSX Venture Exchange.

Xenia Hotels & Resorts, Inc.

XHR Q2 2026

Reported: 2026-08-04

Shares dropped 5.7% following earnings as investors reacted negatively to margin compression and cautious near-term demand outlook, despite modest revenue growth and stable operating metrics. Key Takeaways:

Key takeaways

Same-property RevPAR rose 5.6% year-over-year, driven entirely by rate growth with occupancy flat.
Adjusted EBITDAre reached $78.1 million, slightly above prior expectations, with adjusted FFO per share up 7% from last year at $0.61.
Food and beverage revenue growth was modest due to subdued group demand and tough prior-year comparisons.
Hotel EBITDA margins declined 65 basis points to 28.7%, pressured by lapping prior real estate tax refunds and higher costs linked to food and beverage repositioning.
The sale of the Kimpton RiverPlace Hotel at a low price point reflects potential challenges in certain segments.

Community

See what investors are trading, holding, and sharing

🌐

📈

📊

🏦

🪙

💱

#	Asset	Price	Community %	Type	Currency	Sector

2026 © AllInvestView

Twitter YouTube Reddit Feature Requests Changelog Support Pricing Help

Support email: [email protected]

Terms of Service | Privacy Policy

Free Trackers · Dividend Apps · Tax Reporting · UK · Australia · Germany · Guides · Ticker Logos

Stock Directory · Financial Glossary · Portfolio Templates · Top Dividend Stocks · Investing in US · Investing in UK · Import Guides · Stock Comparison · Earnings Recaps

Data disclaimer: AIV (AllInvestView) assumes no liability for the information presented. Users are encouraged to exercise caution and carefully consider the accuracy, completeness, and relevance of the information provided.

It's important to remember that our website should complement your independent market research rather than replace it. The past performance of assets should not be regarded as a guarantee of future results. AllInvestView is not a registered investment advisor or broker/dealer, and the information presented here is for educational and informational purposes only. We value your trust and are committed to providing you with valuable market insights while emphasizing the importance of responsible decision-making in your investment journey.